Back to search

Netherlands· NL-6f50e75f132d

Ethinylestradiol/levonorgestrel Teva 0,02 mg/0,1 mg, filmomhulde tabletten

A levonorgestrel and ethinylestradiol product containing ethinylestradiol + levonorgestrel, registered in Netherlands by Teva Nederland B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC G03AA07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedEthinylestradiol/levonorgestrel Teva …ATCG03AA07REGISTER NO.NL-6f50e75f132dPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Levonorgestrel and ethinylestradiol is registered in 12 of 19 countries.

Countries holding a registration under ATC G03AA07 (levonorgestrel and ethinylestradiol), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Levonorgestrel and ethinylestradiol · ATC G03AA07

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ETHINYLESTRADIOL + LEVONORGESTREL
Manufacturer
Teva Nederland B.V.
Country
Netherlands (NL)
ATC code
G03AA07
ATC class
Levonorgestrel and ethinylestradiol
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    102388

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

494 interactions on record for levonorgestrel and ethinylestradiol.

Graded by severity as the source publishes them — 40 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Levonorgestrel and ethinylestradiol · interactions on record

494 records

  • 40 severe
  • 372 moderate
  • 49 minor

Most severe, free to view

  • Tranexamic acidB02AA02severe
  • HeminB06AB01severe
  • BosentanC02KX01severe
  • GriseofulvinD01AA08severe

33 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levonorgestrel and ethinylestradiol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levonorgestrel and ethinylestradiol products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Erlidona, Ethinylestradiol/Levonorgestrel Nextpharma
  • Belgium · Eleonor 20, Lavinia
  • Bulgaria · Три-Регол
  • Czechia · Ebelya, Minisiston
  • Germany · Asumate 20, Asumate 30
  • Denmark · Anastrella, Femicept
  • Spain · Aileva, Anaomi
  • France · Adepal, Asterluna
  • United Kingdom (Northern Ireland) · Ambelina, Elevin
  • Croatia · Adexa
  • Hungary · Rigevidon, Seasonique
  • Ireland · Leonore, Levonorgestrel/ Ethinylestradiol Renata Pharmaceuticals (Ireland)
  • Iceland · Levoethin, Melleva
  • Italy · Egogyn, Lasca
  • Lithuania · Rigevidon, Tri - Regol
  • Luxembourg · Levorichter 30, Lowette
  • Latvia · Rigevidon
  • Norway · Melleva, Microgynon
  • Poland · Levomine, Levomine Mini
  • Portugal · Effilevo, Etinilestradiol + Levonorgestrel Generis
  • Romania · Microgynon, Seasonique
  • Sweden · Anastrella, Leverette 21
  • Slovenia · Stediril-M
  • Slovakia · Ebelya, Seasonique

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f66295ba-91e2-42b4-8400-e3901e907d04
GET /v1/drugs/f66295ba-91e2-42b4-8400-e3901e907d04?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h102388_smpc_en.pdf",
  "strength": null,
  "atc_label": "Levonorgestrel And Ethinylestradiol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg102388",
  "excipients": [
    "ALLURAROOD AC ALUMINIUM LAK (E 129)",
    "IJZEROXIDE ROOD  (E 172)",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "LACTOSE 0-WATER",
    "LECITHINE, SOYA (E 322)",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203)",
    "POVIDON K 30 (E 1201)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ETHINYLESTRADIOL",
    "LEVONORGESTREL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h102388_piluk.pdf",
  "authorised_at": "2009/12/16",
  "procedure_number": "NL/H/1380/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "102388",
  "additional_monitoring": "N"
}

See everything about levonorgestrel and ethinylestradiol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.